| |
| |
|
| Insider
Information: |
Christensen Jamie |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
40,600 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
40,600 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -183.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2014-12-05 |
0 |
Premium* |
|
|
Tango Therapeutics Ord Shs |
TNGX |
Director |
2020-09-02 |
40,600 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TNGX |
Tango Therapeutics Ord Sh... |
Director |
– • – |
2020-09-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,600 |
|
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2020-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,625 |
24,784 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
37,842 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,023 |
54,285 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2021-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,856 |
60,706 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2021-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
19,149 |
78,742 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,755 |
88,055 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2022-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
19,149 |
106,089 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2023-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
26,864 |
124,742 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP & Chief Scientific Officer |
• • – |
2024-01-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(154,996) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-01-26 |
4 |
OE |
$5.40 |
$67,500 |
D/D |
12,500 |
15,377 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-06-26 |
4 |
OE |
$5.40 |
$28,123 |
D/D |
5,208 |
8,085 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2019-12-23 |
4 |
OE |
$5.40 |
$36,246 |
D/D |
6,666 |
13,326 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2020-03-26 |
4 |
OE |
$5.40 |
$124,983 |
D/D |
8,058 |
32,842 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
• – – |
2020-11-02 |
4 |
OE |
$5.40 |
$90,493 |
D/D |
10,879 |
48,721 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Science Officer |
• – – |
2017-11-02 |
4 |
OE |
$5.50 |
$41,245 |
D/D |
7,499 |
10,169 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
• – – |
2018-06-27 |
4 |
OE |
$5.50 |
$27,495 |
D/D |
4,999 |
8,393 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP & Chief Scientific Officer |
• – – |
2014-12-05 |
4 |
OE |
$8.50 |
$21,250 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP & Chief Scientific Officer |
• – – |
2015-02-17 |
4 |
OE |
$8.50 |
$3,400 |
D/D |
400 |
1,650 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP & Chief Scientific Officer |
• – – |
2015-02-19 |
4 |
OE |
$8.50 |
$26,350 |
D/D |
3,100 |
4,350 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP & Chief Scientific Officer |
• – – |
2015-03-05 |
4 |
OE |
$8.50 |
$51,000 |
D/D |
6,000 |
7,250 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Science Officer |
• – – |
2017-10-04 |
4 |
OE |
$8.50 |
$34,000 |
D/D |
4,000 |
6,670 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Science Officer |
• – – |
2017-11-16 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
12,670 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Science Officer |
• – – |
2018-01-11 |
4 |
OE |
$8.50 |
$216,805 |
D/D |
14,500 |
16,895 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Science Officer |
• – – |
2017-09-15 |
4 |
AS |
$12.00 |
$9,240 |
D/D |
(770) |
2,670 |
0 |
- |
|
61 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
